PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Amsterdam UMC - Locatie VUmc, Amsterdam

Hospital Clinic Barcelona, Barcelona

New York University (NYU) Clinical Cancer Center, New York

Columbia University College of Physicians & Surgeons, Columbia University, New York

Memorial Sloan Kettering Cancer Center, New York

Viriginia Cancer Specialists, Fairfax

Centro Integral Oncologico Clara Campal, Madrid

Clinica Universidad de Navarra, Pamplona

The Sarah Cannon Research Institute, Nashville

Instituto Valenciano de Oncologia, Valencia

Barbara Ann Karmanos Cancer Institute, Detroit

University of Wisconsin-Carbone Cancer Center, Madison

Rush University Medical Center, Chicago

University of Chicago, Chicago

MD Anderson Cancer Center, Houston

Huntsman Cancer Institute, Salt Lake City

USC Norris Comprehensive Cancer Center, Los Angeles

Providence Portland Medical Center, Portland

Swedish Cancer Institute (SCI), Seattle

Yale University School of Medicine - Yale Cancer Center, New Haven

Dana-Farber Cancer Institute, Boston

Universitair Medisch Centrum Groningen, Groningen

Instituto Catalan de Oncologia - Hospital Duran i Reynals, Barcelona

Beatson, West of Scotland Cancer Centre, Glasgow

Sarah Cannon Research Institute UK Limited, London

Northern Centre for Cancer Care, Newcastle upon Tyne